Study says recurring C. diff infections up 189% from 2001 to 2012

Findings indicate multiple recurring C. diff infections place an increased burden on healthcare system


Multiple recurring Clostridium difficile infections increased 189 percent from 2001 to 2012, according to an article on the Becker's Infection Control & Clinical Quality website.

In contrast, the incidence of C. diff infections rose by about 43 percent.

Researchers labeled the C. diff infections as "multiple recurrent" when the patients were teated with three courses of antibiotics, with little time between each course.

The study suggested the findings indicate multiple recurring C. diff infections place an increased burden on the healthcare system.

Read the article.

 

 



July 12, 2017


Topic Area: Infection Control


Recent Posts

Alleged Ransomware Administrator Extradited from South Korea

The Phobos ransomware has been used globally to target over 1,000 organizations, including healthcare.


Design Plans Unveiled for New Intermountain St. Vincent Regional Hospital

The new hospital will be a 14-floor, 737,000 square-foot facility in Billings, Montana.


Ground Broken on New Pediatric Health Campus in Dallas

The new campus will replace the existing Children’s Medical Center Dallas.


Pre-Construction Strategies for Successful Facilities Projects

Savvy decisions can help facilities meet long-term goals by creating consistency and eliminating waste.


Geisinger Finds Success with Violence Prevention Efforts

Their safety measures included training staff in de-escalation, active-shooter response drills and equipping 6,000 employees with duress notification badges.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.